We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASPU
14526
CALL
DELISTED
ASPEN GROUP, INC.
ASPU
-11,200
Closed -$18K
EWSC
14527
DELISTED
Invesco S&P SmallCap 600 Equal Weight ETF
EWSC
-8,436
Closed -$679K
IIGV
14528
DELISTED
Invesco Investment Grade Value ETF
IIGV
-23,360
Closed -$584K
TETCW
14529
DELISTED
Tech and Energy Transition Corporation Warrant
TETCW
-366,666
Closed -$103K
NOGN
14530
DELISTED
Nogin, Inc. Common Stock
NOGN
-39,460
Closed -$7.87M
SIOX
14531
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-208,065
Closed -$86.1K
QTT
14532
CALL
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
-10,000
Closed -$15K
OBSV
14533
CALL
DELISTED
ObsEva SA Ordinary Shares
OBSV
-16,200
Closed -$24K
OBSV
14534
DELISTED
ObsEva SA Ordinary Shares
OBSV
-21,531
Closed -$35.5K
GXIIW
14535
DELISTED
GX Acquisition Corp. II Warrant
GXIIW
-329,494
Closed -$92K
FTPA
14536
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
-950,469
Closed -$9.29M
FRON
14537
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
-500,174
Closed -$4.9M
FTPAW
14538
DELISTED
FTAC Parnassus Acquisition Corp. Warrant
FTPAW
-209,525
Closed -$79K
FRONW
14539
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
-106,375
Closed -$57K
KINZU
14540
DELISTED
KINS Technology Group Inc. Unit
KINZU
-12,460
Closed -$126K
TBSAW
14541
DELISTED
TB SA Acquisition Corp Warrant
TBSAW
-308,463
Closed -$74K
AGGRW
14542
DELISTED
Agile Growth Corp Warrant
AGGRW
-866,683
Closed -$251K
AGGR
14543
DELISTED
Agile Growth Corp
AGGR
-270,614
Closed -$2.64M
PDOT.WS
14544
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
-88,133
Closed -$33K
PDOT
14545
DELISTED
Peridot Acquisition Corp. II
PDOT
-600,000
Closed -$5.87M
KRBP
14546
CALL
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
-3,810
Closed -$98K
PTOCW
14547
DELISTED
Pine Technology Acquisition Corp. Warrant
PTOCW
-380,855
Closed -$85K
FRSG
14548
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
-630,149
Closed -$6.14M
HERAW
14549
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
-875,000
Closed -$389K
FRSGW
14550
DELISTED
First Reserve Sustainable Growth Corp. Warrant
FRSGW
-91,653
Closed -$28K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.